Document is current

Any future updates will be listed below

Improved disease markers suggest dual response in a patient with metastatic castration resistant prostate cancer and chronic lymphocytic leukemia following active cellular immunotherapy

Crossref DOI link: https://doi.org/10.1186/S13045-015-0149-X

Published Online: 2015-05-14

Published Print: 2015-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark